Omalizumab Before Onset of Exacerbations — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Omalizumab Before Onset of Exacerbations — Stella

Home/Asthma in Children/

View on ClinicalTrials.gov

Recruiting

Back to Asthma in Children trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Children's National Hospital, Washington D.C., District of Columbia

Key details

Phase

Safety & dosing

Sponsor

Children's National Research Institute

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~300 participants

Started

May 2022

Primary completion

January 2028

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

6 Years – 17 Years

Last updated July 2025